Status:

WITHDRAWN

Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema

Lead Sponsor:

Novartis Pharmaceuticals

Conditions:

Diabetic Macula Edema

Eligibility:

All Genders

18-110 years

Phase:

PHASE3

Brief Summary

The purpose of this study is to evaluate the efficacy and safety of brolucizumab in treatment of patients with visual impairment due to diabetic macular edema (DME).

Detailed Description

In this 48-week, randomized, double-masked, multicenter, active controlled study, consenting patients will be randomized in a 1:1 ratio to one of the two treatment arms and attend 14 planned visits.

Eligibility Criteria

Inclusion

  • Patients with type 1 or type 2 diabetes mellitus and HbA1c of ≤10% at Screening
  • BCVA score between 23 and 65 letters, inclusive, using ETDRS visual acuity testing charts at a testing distance of 4 meters (approximate Snellen equivalent of 20/50 to 20/320), at screening and baseline
  • DME involving the center of the macula, with central subfield retinal thickness (measured from RPE to ILM inclusively) of ≥ 320 µm on SD-OCT

Exclusion

  • High risk or advanced proliferative diabetic retinopathy in the study eye as per reading Center
  • Active intraocular or periocular infection or active intraocular inflammation in the study eye
  • Uncontrolled glaucoma in the study eye defined as intraocular pressure (IOP) \> 25 millimeters mercury (mmHg)
  • Previous treatment with any anti-VEGF drugs or investigational drugs in the study eye in the last 3 months prior randomization
  • Stroke or myocardial infarction during the 6-month period prior to baseline
  • Uncontrolled blood pressure defined as a systolic value ≥160 mmHg or diastolic value ≥100 mmHg Other protocol-specified inclusion/exclusion criteria may apply

Key Trial Info

Start Date :

February 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 31 2023

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04079231

Start Date

February 1 2021

End Date

January 31 2023

Last Update

March 4 2021

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.